Abstract:Dependence and impairment of learning and memory are two well-established features caused by abused drugs such as opioids. The hippocampus is an important region associated with both drug dependence and learning and memory. However, the molecular events in hippocampus following exposure to abused drugs such as opioids are not well understood. Here we examined the effect of chronic morphine treatment on hippocampal protein expression by proteomic analyses. We found that chronic exposure of mice to morphine for 10 days produced robust morphine withdrawal jumping and memory impairment, and also resulted in a significant downregulation of hippocampal protein levels of three metabolic enzymes, including Fe-S protein 1 of NADH dehydrogenase, dihydrolipoamide acetyltransferase or E2 component of the pyruvate dehydrogenase complex and lactate dehydrogenase 2. Further real-time quantitative PCR analyses confirmed that the levels of the corresponding mRNAs were also remarkably reduced. Consistent with these findings, lower ATP levels and an impaired ability to convert glucose into ATP were also observed in the hippocampus of chronically treated mice. Opioid antagonist naltrexone administrated concomitantly with morphine significantly suppressed morphine withdrawal jumping and reversed the downregulation of these proteins. Acute exposure to morphine also produced robust morphine withdrawal jumping and significant memory impairment, but failed to decrease the expression of these three proteins. Intrahippocampal injection of D-glucose before morphine administration significantly enhanced ATP levels and suppressed morphine withdrawal jumping and memory impairment in acute morphine-treated but not in chronic morphine-treated mice. Intraperitoneal injection of high dose of D-glucose shows a similar effect on morphine-induced withdrawal jumping as the central treatment. Taken together, our results suggest that reduced expression of the three metabolic enzymes in the hippocampus as a result of chronic morphine treatment contributes to the development of drug-induced symptoms such as morphine withdrawal jumping and memory impairment.

Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia.

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state

Effect of Morphine Dependence and Abstinence on the Expression of B-cell Lymphomal-2 in Sprague-Dawley Rats

Effect of Morphine Dependence on the Ultrastructure of Sprague-Dawley Rats

Proteomic Analysis of Rat Prefrontal Cortex in Three Phases of Morphine-Induced Conditioned Place Preference

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

Proteomic Analysis of PKCγ-Related Proteins in the Spinal Cord of Morphine-Tolerant Rats

Changes of Protein Expression Profiles in the Amygdala During the Process of Morphine-Induced Conditioned Place Preference in Rats

Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention.

Changes of extracellular amino acids levels in related brain regions of rats with psychological dependence on morphine

[Establishment and Differential Protein Identification of Two-Dimensional Gel Electrophoresis for Proteomics in the Spinal Cord of Morphine-Tolerant Rats].

Comparative Proteomic Analysis of the Nucleus Accumbens During Extinction and Reinstatement of Morphine Dependence.

Expression and Localization of Cannabinoid Receptor 1 in Rats’ Brain Treated with Acute and Repeated Morphine

Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine.

Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain.

Chronic morphine administration induces over-expression of aldolase C with reduction of CREB phosphorylation in the mouse hippocampus.

Expression Changes of Hippocampal Energy Metabolism Enzymes Contribute to Behavioural Abnormalities During Chronic Morphine Treatment

Changes of noradrenergic neurons in the spinal cord of morphine-dependence and morphine-withdrawal rat

Single and Repeated Morphine Administrations Differently Regulate Expression of N-Ethylmaleimide-Sensitive Factor Gene in the Rat Brain